...Phase 3 Trial of Sorafenib Plus Erlotinib Vs Sorafenib Plus Placebo As First Line Systemic Treatment for Hcc Grant uri icon

date/time interval

  • 2009 - July 1, 2015

total award amount

  • 82981.24

direct costs

  • 66384.99

sponsor award ID

  • 12917-140

local award ID

  • 00073720